Neurological toll of COVID-19 Shivam BholaJhillika TrisalPradeep Kumar COVID-19 16 January 2022 Pages: 2171 - 2186
Neurological involvement associated with COVID-19 disease: a study on psychosocial factors Arianna MarinielloSilvia SchiavolinAlessandro Padovani COVID-19 22 January 2022 Pages: 2187 - 2193
Neurological emergency at the COVID-19 pandemic: report from a referral hospital in Eastern Piedmont, Italy Claudia VarrasiThomas FleetwoodRoberto Cantello COVID-19 Open access 18 January 2022 Pages: 2195 - 2201
In-hospital and out-of-hospital stroke in patients with COVID-19: two different diseases? Ludovico CiolliVeronica RighiStefano Meletti COVID-19 22 January 2022 Pages: 2203 - 2210
Acute telestroke evaluations during the COVID-19 pandemic Alejandro VargasNicholas D. OsteraasJames J. Conners COVID-19 22 January 2022 Pages: 2211 - 2215
Critical role of acute hypoxemia on the cognitive impairment after severe COVID-19 pneumonia: a multivariate causality model analysis Miguel García-GrimshawAmanda Chirino-PérezErwin Chiquete COVID-19 13 January 2022 Pages: 2217 - 2229
Chronic fatigue syndrome and cognitive deficit are associated with acute-phase neuropsychiatric manifestations of COVID-19: A 9-month follow-up study Fatemeh Sadat MirfazeliAtiye Sarabi-JamabSeyed Hamid Reza Faiz COVID-19 21 January 2022 Pages: 2231 - 2239
Sleep disorders and mental health in hospital workers during the COVID-19 pandemic: a cross-sectional multicenter study in Northern Italy Paola ProserpioElena ZambrelliGiuseppe Didato COVID-19 13 January 2022 Pages: 2241 - 2251
Reliability of televisits for patients with mild relapsing–remitting multiple sclerosis in the COVID-19 era Simona ToscanoFrancesco PattiMario Zappia COVID-19 Open access 11 January 2022 Pages: 2253 - 2261
Effects of quarantine applied during the COVID-19 pandemic on mental health and quality of life in patients with multiple sclerosis and healthy controls Emine Rabia KocAylin Bican DemirGuvan Ozkaya COVID-19 21 January 2022 Pages: 2263 - 2269
Myasthenia gravis exacerbation and myasthenic crisis associated with COVID-19: case series and literature review Cleonisio Leite RodriguesHermany Capistrano de FreitasPaulo Ribeiro Nóbrega COVID-19 18 January 2022 Pages: 2271 - 2276
EEG changes in intensive care patients diagnosed with COVID-19: a prospective clinical study Omer KaradasBilgin OzturkAkcay Ovunc Ozon COVID-19 23 January 2022 Pages: 2277 - 2283
Visual evoked potential and nerve conduction study findings in patients recovered from COVID-19 Asli KoskdereliogluNeslihan EskutSelma Tosun COVID-19 14 January 2022 Pages: 2285 - 2293
SARS-CoV-2 vaccine-related neurological complications Nicol G. M. OonkAnne Rozemarijn EttemaMatthijs van der Meulen COVID-19 20 January 2022 Pages: 2295 - 2297
Audio-visual stimulation for visual compensatory functions in stroke survivors with visual field defect: a systematic review Kholoud AlwashmiGeorg MeyerFiona J. Rowe Review Article Open access 11 February 2022 Pages: 2299 - 2321
Effects of cognitive rehabilitation in Parkinson disease: a meta-analysis Andreina GiustinianiLorenza MaistrelloFrancesca Burgio Review Article 31 January 2022 Pages: 2323 - 2337
Neurotoxicity and safety of the rechallenge of immune checkpoint inhibitors: a growing issue in neuro-oncology practice M. Villagrán-GarcíaR. Velasco Review Article 17 February 2022 Pages: 2339 - 2361
Neurological side effects of radiation therapy J. JacobL. FeuvretP. Maingon Review Article 11 February 2022 Pages: 2363 - 2374
Whole blood viscosity is associated with baseline cerebral perfusion in acute ischemic stroke Prajwal GyawaliThomas Patrick LillicrapNeil Spratt Original Article Open access 20 October 2021 Pages: 2375 - 2381
Atrial cardiopathy predicts detection of atrial fibrillation in embolic stroke of undetermined source: real-life data Ana Rita SilvaCarla PiresJoão Pinho Original Article 27 October 2021 Pages: 2383 - 2386
Coexisting of aortic arch atheroma and atrial fibrillation for short-term recurrence and poor functional outcome in acute stroke Yuhei AnanTakafumi MashikoShigeru Fujimoto Original Article 08 November 2021 Pages: 2387 - 2396
The risk factors of old silent brain infarctions in carotid artery stenosis Xiaodong LiuChen WangYujie Wang Original Article 29 September 2021 Pages: 2397 - 2404
Clinical features of Trousseau’s syndrome with multiple acute ischemic strokes Yitong LingYinye LiJintao Wang Original Article 26 September 2021 Pages: 2405 - 2411
Cardio-cerebral infarction in left MCA strokes: a case series and literature review Elochukwu IbekweHera A. KamdarTamara Strohm Original Article 29 September 2021 Pages: 2413 - 2422
Heart rate variability and delirium in acute non-cardioembolic stroke: a prospective, cross-sectional, cohort study Eleonora RolloJessica MarottaGiacomo Della Marca Original Article Open access 29 September 2021 Pages: 2423 - 2431
Fabry-Stroke Italian Registry (FSIR): a nationwide, prospective, observational study about incidence and characteristics of Fabry-related stroke in young-adults. Presentation of the study protocol Ilaria RomaniPatrizia NenciniDomenico Inzitari Original Article Open access 05 October 2021 Pages: 2433 - 2439
Anticoagulation after intracerebral hemorrhage in patients with atrial fibrillation: between Scylla and Charybdis Carla Seabra AbrantesMariana PintalhãoPaulo Castro Chaves Original Article 20 September 2021 Pages: 2441 - 2448
Construction of a nomogram to reveal the prognostic benefit of spontaneous intracranial hemorrhage among Chinese adults: a population-based study Gui-Jun ZhangJie-Yi ZhaoXiao-Yu Wang Original Article 25 October 2021 Pages: 2449 - 2460
A retrospective study on risk factors and disease burden for hospital-acquired pneumonia caused by multi-drug-resistant bacteria in patients with intracranial cerebral hemorrhage Haojun YangYishu FanWeiping Liu Original Article 08 November 2021 Pages: 2461 - 2467
Cerebral amyloid load determination in a clinical setting: interpretation of amyloid biomarker discordances aided by tau and neurodegeneration measurements Matilde NerattiniFederica RubinoValentina Berti Original Article 05 November 2021 Pages: 2469 - 2480
The patient–caregiver dyad: the impact of cognitive and functional impairment Valeria TorlaschiMarina MaffoniCira Fundarò Original Article 13 November 2021 Pages: 2481 - 2490
Standardization and normative data for a new test of visual long-term recognition memory Edoardo BarvasGiulia MattavelliCostanza Papagno Original Article 06 October 2021 Pages: 2491 - 2497
Gender differences in cognitive reserve: implication for subjective cognitive decline in women Giulia GiacomucciSalvatore MazzeoValentina Bessi Original Article Open access 08 October 2021 Pages: 2499 - 2508
Nutritional status and dynapenia in people living with Parkinson’s disease: a cross-sectional study Luís César de MedeirosMarcella Campos Lima da LuzPoliana Coelho Cabral Original Article 22 October 2021 Pages: 2509 - 2517
Development and validation of an instrument for measuring parkinsonian motor impairment: TRAPS-D José Oswaldo de Oliveira JúniorRosimary Amorim LopesRicardo Vieira Botelho Original Article 28 October 2021 Pages: 2519 - 2524
Frequency of hand movements as a possible diagnostic tool for parkinsonian bradykinesia. Proposal of a simple bedside test Yacov BalashRonit Gilad Original Article 14 October 2021 Pages: 2525 - 2529
Polysomnographic correlates of sleep disturbances in de novo, drug naïve Parkinson’s Disease Beatrice OrsoFrancesco FamàDario Arnaldi Original Article Open access 29 September 2021 Pages: 2531 - 2536
Safinamide improves sleep and daytime sleepiness in Parkinson’s disease: results from the SAFINONMOTOR study Diego Santos GarcíaIria Cabo LópezCristina Martínez Miró Original Article 23 September 2021 Pages: 2537 - 2544
Use of antipsychotics and long-term risk of parkinsonism Angelo d’ErricoElena StrippoliFulvio Ricceri Original Article Open access 15 October 2021 Pages: 2545 - 2553
Different phenotypes of neurological diseases, including alternating hemiplegia of childhood and rapid-onset dystonia-parkinsonism, caused by de novo ATP1A3 mutation in a family Wen WeiXiu-fen ZhengYun-fei Li Original Article 16 November 2021 Pages: 2555 - 2563
Restless legs syndrome affecting the head region: “restless head syndrome” Ferhat BalgetirMurat GönenBülent Müngen Original Article 18 October 2021 Pages: 2565 - 2570
ALS Cognitive Behavioral Screen-Phone Version (ALS-CBS™-PhV): norms, psychometrics, and diagnostics in an Italian population sample Edoardo Nicolò AielloAntonella EspositoIldebrando Appollonio Original Article Open access 02 October 2021 Pages: 2571 - 2578
Genetic analysis in Chinese patients with familial or young-onset amyotrophic lateral sclerosis Jing MaXiaomin PangWei Zhang Original Article 26 September 2021 Pages: 2579 - 2587
Assessment of gait and balance impairment in people with spinocerebellar ataxia using wearable sensors He ZhouHung NguyenAshkan Vaziri Original Article 19 October 2021 Pages: 2589 - 2599
Multiple sclerosis and genetic polymorphisms in fibrinogen-mediated hemostatic pathways: a case–control study Gianmarco AbbadessaGiuseppina MieleSimona Bonavita Original Article Open access 24 September 2021 Pages: 2601 - 2609
Association of cholesterol 7α-hydroxylase (CYP7A1) promoter polymorphism (rs3808607) and cholesterol 24S-hydroxylase (CYP46A1) intron 2 polymorphism (rs754203) with serum lipids, vitamin D levels, and multiple sclerosis risk in the Turkish population Eda SezerBirsen Can DemirdöğenOrhan Adalı Original Article 21 September 2021 Pages: 2611 - 2620
Significance of serum VIP and PACAP in multiple sclerosis: an exploratory case–control study Maha S. Al-KeilaniBasima A. AlmomaniSaied A. Jaradat Original Article 26 October 2021 Pages: 2621 - 2630
Dentate-nucleus gadolinium deposition on magnetic resonance imaging: ultrasonographic and clinical correlates in multiple sclerosis patients Isabelle KühnHenning MaschkeUwe Walter Original Article Open access 04 November 2021 Pages: 2631 - 2639
Fingolimod as a first- or second-line treatment in a mini-series of young Hellenic patients with adolescent-onset multiple sclerosis: focus on immunological data Maria GontikaCharalampos SkarlisMaria Anagnostouli Original Article 01 October 2021 Pages: 2641 - 2649
Efficacy of azathioprine, mycophenolate mofetil, and rituximab in the treatment of neuromyelitis optica spectrum disorder and analysis of prognostic factors Lu ZhangJingyuan TianBin Li Original Article 28 September 2021 Pages: 2651 - 2658